Selective portal clamping to minimize hepatic ischaemia-reperfusion damage and avoid accelerated outgrowth of experimental colorectal liver metastases

British Journal of Surgery

Volumn 93, Issue 8, 2006, Pages 1015-1022

  Van Der Bilt, J D W ^a   Kranenburg, O ^a   Verheem, A ^a   Van Hillegersberg, R ^a   Borel Rinkes, I H M ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Surgery ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; HEPATIC ARTERY; INFLAMMATION; LIVER CELL DAMAGE; LIVER INJURY; LIVER ISCHEMIA; LIVER LOBECTOMY; LIVER METASTASIS; LIVER NECROSIS; LIVER PARENCHYMA; MICROMETASTASIS; MOUSE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; REPERFUSION INJURY; TISSUE INJURY; TUMOR GROWTH;

ANIMALS; COLORECTAL NEOPLASMS; CONSTRICTION; HEPATECTOMY; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; REPERFUSION INJURY;

EID: 33747047577     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5382     Document Type: Article

References (45)

1. International Agency for Research on Cancer. Globocan 2002 Cancer incidence, mortality and prevalence worldwide (2002 estimates). http://www-dep.iarc.fr/ [16 September 2005].
2. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969; 23: 198-202.
3. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285-288.
4. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508.
5. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
6. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-946.
7. Fioole B, Liem MS, Hennipman A, Borel Rinkes IH. [Partial liver resections: mortality, morbidity and risk factors for postoperative complications in 133 patients/137 operations; Utrecht University Medical Center 1991/2000.] Ned Tijdschr Geneeskd 2002; 146: 210-213.
8. Selzner M, Clavien PA. Resection of hepatic tumors: special emphasis on neoadjuvant and adjuvant therapy. In Malignant liver tumors: current and emerging therapies (2nd edn), Clavien PA (ed). Jones and Bartlett Publishers: Sudbury, MA, 2004; 153-169.
9. Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 2003; 39: 2150-2164.
10. Nikfarjam M, Christophi C. Interstitial laser thermotherapy for liver tumours. Br J Surg 2003; 90: 1033-1047.
11. Christophi C, Nikfarjam M, Malcontenti-Wilson C, Muralidharan V. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy. World J Surg 2004; 28: 987-994.
12. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005; 127: 208-223.
13. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171.
14. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
15. Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG. Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 2004; 230: 450-458.
16. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-166.
17. Kuvshinoff B W, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002; 132: 605-611.
18. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88: 2452-2463.
19. Isbert C, Roggan A, Ritz JP, Muller G, Buhr HJ, Lehmann KS et al. Laser-induced thermotherapy: intra- and extralesionary recurrence after incomplete destruction of experimental liver metastasis. Surg Endosc 2001; 15: 1320-1326.
20. Heisterkamp J, van Hillegersberg R, Mulder PG, Sinofsky EL, IJzermans JN. Importance of eliminating portal flow to produce large intrahepatic lesions with interstitial laser coagulation. Br J Surg 1997; 84: 1245-1248.
21. Albrecht D, Germer CT, Isbert C, Ritz JP, Roggan A, Muller G et al. Interstitial laser coagulation: evaluation of the effect of normal liver blood perfusion and the application mode on lesion size. Lasers Surg Med 1998; 23: 40-47.
22. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227: 559-565.
23. Scott DJ, Fleming JB, Watumull LM, Lindberg G, Tesfay ST, Jones DB. The effect of hepatic inflow occlusion on laparoscopic radiofrequency ablation using simulated tumors. Surg Endosc 2002; 16: 1286-1291.
24. Rossi S, Garbagnati F, De Francesco I, Accocella F, Leonardi L, Quaretti P et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 1999; 85: 128-132.
25. Aschoff AJ, Merkle EM, Wong V, Zhang Q, Mendez MM, Duerk JL et al. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver? J Magn Reson Imaging 2001; 13: 57-63.
26. Takamura M, Murakami T, Shibata T, Ishida T, Niinobu T, Kawata S et al. Microwave coagulation therapy with interruption of hepatic blood in- or outflow: an experimental study. J Vasc Interv Radiol 2001; 12: 619-622.
27. Wiersinga WJ, Jansen MC, Straatsburg IH, Davids PH, Klaase JM, Gouma DJ et al. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg 2003; 90: 306-312.
28. Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637-647.
29. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26.
30. Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury - a fresh look. Exp Mol Pathol 2003; 74: 86-93.
31. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005; 42: 165-175.
32. Drixler TA, Borel Rinkes IHM, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 2000; 60: 1761-1765.
33. te Velde EA, Vogten JM, Gebbink MF, van Gorp JM, Voest EE, Borel Rinkes IHM. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model. Br J Surg 2002; 89: 1302-1309.
34. Metzger H, Heuber-Metzger S. The hypoxic response to hypovolemia. Acta Exp Med Biol 1984; 180: 599-607.
35. Heijnen BH, Elkhaloufi Y, Straatsburg IH, Van Gulik TM. Influence of acidosis and hypoxia on liver ischemia and reperfusion injury in an in vivo rat model. J Appl Physiol 2002; 93: 319-323.
36. Heijnen BH, van Veen SQ, Straatsburg IH, van Gulik TM. Pronounced effect of minor changes in body temperature on ischemia and reperfusion injury in rat liver. J Appl Physiol 2001; 91: 265-268.
37. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47.
38. Brahimi-Horn C, Berra E, Pouyssegur J. Hypoxia: the tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol 2001; 11: S32-S36.
39. Denys AL, De Baere T, Mahe C, Sabourin JC, Sa Cunha A, Germain S et al. Radio-frequency tissue ablation of the liver: effects of vascular occlusion on lesion diameter and biliary and portal damages in a pig model. Eur Radiol 2001; 11: 2102-2108.
40. Ezaki T, Yamaguchi H, Sasaki Y, Ishida T, Fujiwara M. Hepatic resection under selective portal vein occlusion using degradable starch microspheres. A simple procedure of an experimental study using the pig. Hepatogastroenterology 2001; 48: 102-103.
41. Ritz JP, Lehmann K, Isbert C, Roggan A, Germer CT, Buhr HJ. Effectivity of laser-induced thermotherapy: in vivo comparison of arterial microembolization and complete hepatic inflow occlusion. Lasers Surg Med 2005; 36: 238-244.
42. Goldberg SN, Charboneau JW, Dodd GD III, Dupuy DE, Gervais DA, Gillams AR et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335-345.
43. Vogl TJ, Straub R, Zangos S, Mack MG, Eichler K. MR-guided laser-induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperthermia 2004; 20: 713-724.
44. Ahmed M, Goldberg SN. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004; 20: 781-802.
45. Veenendaal LM, van Hillegersberg R, Smakman N, van der Bilt JD, van Diest PJ, Kranenburg O et al. Synergistic effect of interstitial laser coagulation and doxorubicin in a murine tumor recurrence model of solitary colorectal liver metastasis. Ann Surg Oncol 2006; 13: 168-175.